SCHEMBL4518407

SCHEMBL4518407

CCc1c(-c2ccc(OC)cc2)[nH]c2ccc(Oc3c(Cl)cc(NC(=O)CC(=O)O)cc3Cl)cc12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.45
MTNR1B P49286 3/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PPARG P37231 1/20 0.44
THRB P10828 4/20 0.43
THRA P10827 3/20 0.43
EPHX1 P07099 3/20 0.42
EPHX2 P34913 3/20 0.42
CNR1 P21554 1/20 0.42
RORC P51449 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4517480 0.89 THRA (0.49) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL4531924 0.87 THRA (0.46) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL4513504 0.75 PPARG (0.49) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL4522383 0.74 THRB (0.52) PPARGTHRBTHRA
SCHEMBL4526597 0.73 THRB (0.49) KDM4EALDH1A1HPGDCYP1A2PPARG
SCHEMBL4532920 0.72 THRA (0.49) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL6510900 0.72 THRB (0.74) THRBTHRARORC
SCHEMBL3990238 0.71 TSPO (0.46) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL4525261 0.71 PPARG (0.43) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL3991568 0.70 TLR8 (0.49) MTNR1AMTNR1BKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA MTNR1A 48/4885MTNR1B 63/4885KDM4E 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.